Is there evidence for correct diagnosis in cystic fibrosis registries?

Journal of Cystic Fibrosis

Volumn 13, Issue 3, 2014, Pages 275-280

  Thomas, Muriel ^a   Lemonnier, Lydie ^b   Gulmans, Vincent ^c   Naehrlich, Lutz ^d   Vermeulen, François ^e   Cuppens, Harry ^f   Castellani, Carlo ^g   Norek, Aleksandra ^h   De Boeck, Kris ^e  

^a Registre Belge de la Mucoviscidose Belgisch Mucoviscidose Register Belgian CF registry (BMR RBM) Scientific Institute of Public Health (WIV ISP)   (Belgium)

^b Vaincre la Mucoviscidose ^*  (France)

^c Dutch CF Foundation (NCFS)   (Netherlands)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g UNIVERSITY HOSPITAL OF VERONA   (Italy)

^h INSTITUTE OF MOTHER AND CHILD   (Poland)

Author keywords

Cystic fibrosis; Diagnosis; Registry

Indexed keywords

CHLORIDE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR PROTEIN, HUMAN;

ARTICLE; CYSTIC FIBROSIS; DIAGNOSTIC TEST; DISEASE REGISTRY; FRANCE; GENE MUTATION; GERMANY; HUMAN; NETHERLANDS; PANCREAS; REGISTER; SWEAT; ADOLESCENT; ADULT; AGED; CHILD; DIAGNOSTIC ERROR; EUROPE; FEMALE; GENETICS; MALE; MIDDLE AGED; QUALITY CONTROL; STANDARDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BENCHMARKING; CHILD; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIAGNOSTIC ERRORS; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; YOUNG ADULT;

EID: 84897109857     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.10.010     Document Type: Article

References (16)

1. Boyle M.P. Nonclassic cystic fibrosis and CFTR-related diseases. Curr Opin Pulm Med Nov 2003, 9(6):498-503.
2. Bombieri C., Claustres M., De Boeck K., Derichs N., Dodge J., Girodon E., et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros Jun 2011, 10(Suppl. 2):S86-S102.
3. De Boeck K., Wilschanski M., Castellani C., Taylor C., Cuppens H., Dodge J., et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax Jul 2006, 61(7):627-635.
4. Goubau C., Wilschanski M., Skalicka V., Lebecque P., Southern K.W., Sermet I., et al. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis. Thorax Aug 2009, 64(8):683-691.
5. Farrell P.M., Rosenstein B.J., White T.B., Accurso F.J., Castellani C., Cutting G.R., et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr Aug 2008, 153(2):S4-S14.
6. Castellani C. CFTR2: how will it help care?. Paediatr Respir Rev May 2013, 14(Suppl. 1):2-5.
7. Watson M.S., Cutting G.R., Desnick R.J., Driscoll D.A., Klinger K., Mennuti M., et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med Sep 2004, 6(5):387-391.
8. Wang X., Dockery D.W., Wypij D., Fay M.E., Ferris B.G. Pulmonary function between 6 and 18years of age. Pediatr Pulmonol Feb 1993, 15(2):75-88.
9. Hankinson J.L., Odencrantz J.R., Fedan K.B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med Jan 1999, 159(1):179-187.
10. Lee T.W., Brownlee K.G., Conway S.P., Denton M., Littlewood J.M. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros Mar 2003, 2(1):29-34.
11. Boyle M.P., De Boeck K. A new era in the treatment of cystic fibrosis: correction of underlying the CFTR defect. Lancet Resp Med 2013, 1:158-163.
12. Viviani L., Zolin A., Olesen H.V. European Cystic Fibrosis Society Patient Registry - annual report 2008-2009 http://www.ecfs.eu/files/webfm/webfiles/File/ecfs_registry/ECFSPR_Report0809_v32012.pdf.
13. Cystic Fibrosis Australia Annual report Australian Cystic Fibrosis Data Registry 2011 http://www.cysticfibrosis.org.au/media/wysiwyg/CF-Australia/medical-documents/ACFDR_2011/ACFDR_2011_Report.pdf.
14. Cystic Fibrosis Canada The Canadian Cystic Fibrosis Registry 2011 annual report http://www.cysticfibrosis.ca/assets/files/pdf/Registry2011FINALOnlineEN.pdf.
15. Scotet V., Audrezet M.P., Roussey M., Rault G., Dirou-Prigent A., Journel H., et al. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?. Pediatrics Nov 2006, 118(5):e1523-e1529.
16. Naehrlich L., Bagheri-Behrouzi A. Misdiagnosis of cystic fibrosis: experience from Germany. J Cyst Fibros Jan 2013, 12(1):68-73.